Books

Guía de seguridad hospitalaria

La Guía de seguridad hospitalaria es un recurso para personas con la enfermedad de Parkinson (EP) y sus aliados en el cuidado, repleta de información y herramientas útiles para estar preparados para una estancia hospitalaria.

¿Por qué es importante la seguridad hospitalaria para las personas con la enfermedad de Parkinson? Las personas con la EP tienen un mayor riesgo de hospitalización y enfrentan muchos desafíos durante su estancia en el hospital. Es posible que el personal del hospital no sepa lo suficiente acerca del Parkinson como para comprender los síntomas o saber que pueden empeorar cuando la medicación para la EP no se suministra a tiempo. Una preparación cuidadosa y una comunicación clara pueden ayudar a minimizar las complicaciones y el tiempo de recuperación.

La Guía de seguridad hospitalaria ofrece información y herramientas útiles para ayudarle a abogar por la mejor atención posible, como:

  • Las cinco necesidades de atención para el Parkinson
  • Formularios para llenar con datos sobre cuidados personales y horarios de medicación
  • Consejos para aliados en el cuidado
  • Información sobre los cuidados del Parkinson para compartir con el equipo médico del hospital

SOLICITAR LA GUÍA

Podcasts

Episodio 26: La hospitalización con la enfermedad de Parkinson

Las investigaciones han encontrado que 3 de cada 4 personas con la enfermedad de Parkinson no reciben medicamentos a tiempo cuando están internadas en el hospital. Cuando esto ocurre, 2 de cada 3 personas experimentarán complicaciones innecesarias. 

Con visitas hospitalarias más a menudo y una alta sensibilidad a la frecuencia y dosificación de los medicamentos para la enfermedad de Parkinson, las personas con Parkinson enfrentan grandes riesgos en un hospital.

En este episodio, hablamos con Adrian Mireles acerca de sus experiencias en el hospital desde su diagnóstico de Parkinson. Adrian comparte los desafíos que ha enfrentado cuando ha estado hospitalizado y qué le resultó útil durante esas visitas, como el kit de seguridad hospitalaria Aware in Care de la Parkinson’s Foundation. 

Adrian también explica lo que significa ser su propio promotor y comparte consejos para otras personas con la enfermedad de Parkinson acerca de cómo conseguir una mejor atención en el hospital.

Publicado: 16 de mayo de 2023

My PD Story

Steve Lounsbury and his wife
People with PD

Steve Lounsbury

I was diagnosed with Parkinson’s disease (PD) in September 2009. My DBS story began in June 2020, when I underwent three surgeries to have a deep brain stimulator (DBS) installed in my head. A DBS device is similar to a cardiac pacemaker, except it sends electrical shocks to my brain instead of my heart. The benefits of said stimulator are relief from some Parkinson's symptoms, including tremor, bradykinesia and rigidity/stiffness. Successful DBS surgery also allows people with PD to reduce their medication.

My first surgery took place on June 9. The surgeon inserted screws into my cranium and used an MRI to take a picture of my brain. This was an outpatient surgery and I found it to be the most painful recovery of the three surgeries.

My second surgery took place on June 19. The surgeon opened my brain to insert an electrical circuit. With assistance from my neurologist and a trusted PA, my surgeon placed two leads: one in the right and one in the left side of my brain. The leads helped improve function on opposite sides of my body. The last step was to connect the wiring to the leads and wind up the wiring under my skin, for the future connection to the neurogenerator. This was an inpatient surgery requiring one night's stay. After a well-deserved night of pampering, I returned home in preparation for the final surgery.

My third and final surgery, to connect the system, took place on June 29. This was an outpatient surgery that placed the neurogenerater under the skin in my chest and connected the pieces of my three-piece brain puzzle. The surgeon used a ‘boring’ tool to create a tunnel from behind my ear down my neck to the neurogenerator to complete the circuit.

I understand that currently, they are offering a single surgery of a longer duration instead of the three I experienced. I believe that this all-in, one-time surgery still includes the option of being awake during the second procedure. If you trust your neurologist and surgeon completely (as I did, do, and always will) and you think you can handle staying awake during surgery, I promise that you won't regret it. I found it to be the most fascinating experience in my life! I wasn't in pain, and I was able to communicate with my neurologist as I watched him 'tune in' the system by testing my arms and legs for rigidity.

Two weeks later, they turned the system on. My wife and I watched as my neurologist adjusted the frequency and amplitude and the tremors miraculously melted away! Tears welled up in my eyes as I rose from my chair and walked, without freezing, right out the door.

This is not where my story ends, though. I was told that the battery life in my neurogenerator would last some three to five years but would probably need replacing sooner. On the day before Thanksgiving (November 23, 2022), the iPod that I used to monitor my neurogenerator indicated in yellow that I should replace the neurogenerator as the battery was losing its strength. I called and scheduled my replacement surgery, which was delayed until December 27 due to the holidays and a blizzard.

Steve Lounsbury and his family

In the four days between Christmas Eve and the rescheduled day of surgery, my neurogenerator had failed completely and as expected, my condition worsened steadily as my brain wasn't generating enough dopamine. The tremors, bradykinesia and rigidity were taking over. The only relief I found was when I slept.

The doubts began to creep in: What if my neurosurgeon couldn't turn on the new neurogenerator right away? What if the DBS didn't function as well as I had previously experienced? After all, my symptoms had progressed since my original surgeries; would the DBS be able to keep up?

Upon my return home after the surgery, I went to take a nap. In that moment, I suddenly understood the wave of emotions that Ebenezer Scrooge experienced as he gleefully repeated, "I don't deserve to be this happy." I had been given not one, but two, opportunities for redemption in my life! The significance of the first I had minimized and attributed to the marvels of modern science. But the second has stricken me so powerfully, I feel compelled to share my story in hopes that it might encourage someone else to consider DBS!

I am grateful to all the neurosurgeons, neurologists, PAs, nurses, anesthesiologists and support staff personnel who work to help people with Parkinson’s disease live better lives. I am also grateful to the Parkinson’s Foundation for providing resources to the PD community. I have attended symposiums and used their online exercises classes to learn more about Parkinson’s and manage my disease. I have also used their legal resources at times.

Finally, I cannot express in words how grateful I am to my wife and soulmate whom I so wisely married over 34 years ago.

Listen to our podcast episode on deep brain stimulation.

My PD Story

Ray Hayden and his dog
People with PD

Ray Hayden

I was officially diagnosed with Parkinson’s disease (PD) at age 62, although I've had tremors (along with what I now recognize were other, less obvious PD symptoms) for many years prior. I was told by numerous physicians not to be concerned regarding the tremors; essential tremors are not uncommon, so I pretty much ignored the red flags.

In early 2020 I found that I was having an extremely difficult time initiating a step when walking, so I decided to check with my PCP. In February 2020, while doing my physical exam, a small town, country doctor noticed the twitching in my fingers. The tremors combined with my start hesitation resulted in a recommendation that I see a neurologist. The rest, as they say, is history.

After receiving my diagnosis, I did extensive research on the Internet and found the Parkinson's Foundation website to be outstanding. Their online information library was extremely helpful in learning more about PD, and I have assembled quite a collection of wonderful info about PD thanks to their resources.

We had a very nice little cabin in rural, northern New Mexico, but the medical care was lacking in the area for someone with PD. When I retired, we moved to the Albuquerque metro area. I miss the beauty, solitude and seclusion of the Sangre de Cristo mountains, but I found a movement disorders specialist in Albuquerque and she has been absolutely awesome.

I am basically learning how to overcome the challenges of being a person with Parkinson’s disease by having access to opportunities that were not readily available prior to relocating. I actually feel blessed, and I refuse to be defined by Parkinson’s. My life, even with the daily rigors of dealing with a progressive disease, has been very rewarding!

I am reminded of a quote which, for a person with PD, I believe are words to live by:
"We cannot change the cards we are dealt, just how we play the hand."

The Parkinson’s Foundation is here to help. Explore Parkinson’s disease resources in our PD Library

My PD Story

Christi Rouse-Deloach headshot
People with PD

Christi Rouse-Deloach

I have always believed the old adage that if you feel something is off or wrong, then it probably is. Life began to change when I could no longer teach my fitness classes without extreme muscle spasms, when I couldn't complete a 5K due to leg pain and weakness, when my hand began to shake without explanation and when going to work as a physical education teacher caused a level of fatigue and brain fog that I had never experienced. Each of these symptoms caused me to fear that I would no longer be able do the things I loved.

I was under the care of both a great chiropractor and physical therapist who urged me to find answers when there seemed to be none. It became a guessing game and a myriad of tests that never produced the answer. No one could tell me what was wrong, so how I was supposed to get back to normal?

After almost a year of testing in my local area and being told many different things without solutions, I reached out to a major research hospital which was seven and a half hours away from my home. Luckily, I was accepted as a patient and when I walked in the doors, I knew that I was in the correct place.

After a series of visits, I received a telephone call that would change my life and give me an answer to what had been ailing me for almost two years. The physician informed that she believed I had young-onset Parkinson's disease (YOPD).

While I never expected this diagnosis, I knew that Parkinson’s was manageable because I have a coworker who was also diagnosed with YOPD several years ago. Once I started medication, I began to get my life back. My movement disorders specialist told me about the Parkinson’s Foundation and the resources available for people living with PD. I was able to virtually attend a symposium to learn more about the disease.

I still can't run like I did before YOPD symptoms began, but I can box, teach my fitness classes and lift weights effectively. When I’m at home, I use Fitness Friday videos to stay moving. I learned that it is imperative to stand up for yourself and not give up on answers. If you ever find yourself on a diagnosis journey, don't give up! I believe that had I not continued to search for answers, my condition would have been much worse before I knew the cause of my symptoms

I now choose to spread awareness of YOPD through education, exercise and encouragement for those living with the same condition.

Explore resources for the Parkinson’s community.

Podcasts

Episode 150: Dispelling Myths of Palliative Care

A common misconception is that palliative care implies hospice, when in fact, palliative care can and should be a component of the treatment of any serious disease, including Parkinson’s. The word “palliation” means providing relief from pain and other symptoms, with a goal of improving quality of life. Individuals receiving palliative care also may receive other treatments, with curative intent if available. On the other hand, palliation can be a part of hospice, but in hospice, a person no longer has curative options or chooses not to pursue them. In this episode, Maggie Ivancic, MSW, LCSWA, the Clinical Social Worker and Parkinson’s Foundation Center of Excellence Coordinator at the University of North Carolina at Chapel Hill, discusses aspects of palliative care – how it differs from hospice, its intent, and how and where to access it.

Released: May 2, 2023

Podcasts

Episodio 25: Opciones quirúrgicas en el tratamiento de la enfermedad de Parkinson

Aunque los medicamentos suelen ayudar a minimizar las fluctuaciones motoras de la enfermedad de Parkinson, hay ocasiones en las que la medicación no es suficiente y se plantean opciones de tratamiento avanzadas.

Es importante explorar las opciones quirúrgicas con su especialista en la EP si esto es algo que puede considerar. La cirugía a menudo se reserva para quienes han optimizado y agotado los medicamentos para el temblor de Parkinson o que experimentan profundas fluctuaciones motoras.

En este episodio de podcast, escuchamos al Dr. Gonzalo Revuelta, profesor asociado de neurología y director médico del programa de estimulación cerebral profunda en MUSC, la Medical University of South Carolina, sobre las opciones de tratamiento quirúrgico disponibles para las personas con la enfermedad de Parkinson. 

Publicado: 25 de abril de 2023

Videos & Webinars

Expert Briefing: Freezing and Fall Prevention in Parkinson's

April 12, 2023

While aging may put us all at an increased risk for falling, people living with Parkinson’s disease have twice the risk of their peers. Falls often result in injuries ranging from minor cuts to serious fractures, impacting mobility and quality of life. Learn how freezing and other movement and non-movement symptoms can contribute to falls and how to lessen the risk.

Download Slides

Presenter

Colum MacKinnon, PhD
Professor, Department of Neurology, Institute of Translational Neuroscience, University of Minnesota

Podcasts

Episode 148: How to Prevent Sudden “Off” Episodes

“Off” episodes can become a troubling aspect of Parkinson’s disease (PD), especially as the disease progresses. These are periods in the day when the effect of levodopa medication wears off, either suddenly or gradually, with a return of motor or non-motor symptoms. 

The good news is that there are several ways to try to minimize “off” episodes, including medication timing, medication adjustments, and add-on medications. In this podcast episode, Dr. George Kannarkat, a movement disorders fellow at the University of Pennsylvania in Philadelphia, a Parkinson’s Foundation Center of Excellence, discusses “off” episodes, their causes, strategies that people can use today to minimize them, and what new technologies are here or coming along to help lessen them.

Released: April 4, 2023

Raise Awareness

Parkinson’s & Medications: What's New?

Woman talking on the phone, holding a pill bottle

Research is actively underway to develop new medications that can slow or stop Parkinson’s disease (PD) progression, while also working to improve the lives of people living with PD today. Learn how lifestyle choices and medication therapy can help you manage Parkinson’s symptoms and what is in the pipeline for 2023.

This article is based on Parkinson’s & Medications - What's New, a Parkinson’s Foundation Expert Briefing webinar presented by Tanya Simuni, MD, Northwestern University Feinberg School of Medicine, Director Parkinson’s Disease and Movement Disorders Center, a Parkinson’s Foundation Center of Excellence.

Stay Informed

For the latest about Medications explore our Treatment webpages.

Moving Science Forward

Globally, Parkinson's is the most rapidly increasing neurological disease and is currently the second most common neurodegenerative disease after Alzheimer's. Researchers are prioritizing science to help them understand the biology behind Parkinson’s disease.

Genetic research is one area that shows promise to push the science forward. However, research seeking to better understand the causes of PD and clinical trials to develop promising new therapies can only happen if people participate in the studies. Participating in a study can also help those living with Parkinson’s better understand their disease.

Current Medication Options

There are several medications available today designed to help manage various Parkinson’s symptoms. Most symptoms stem from a lack of the chemical dopamine in the brain. Many PD medicines either temporarily replenish dopamine or mimic its action.

Levodopa, which converts to dopamine, paired with carbidopa, is considered a first-line drug for improving movement challenges, such as tremor and slowness, and other PD movement symptoms. It can dramatically improve quality of life and can be delivered in a variety of formulations, including carbidopa/levodopa immediate, controlled and extended release, as well as preparations that can be inhaled or delivered through a surgically implanted tube in the small intestine. As Parkinson’s progresses, people may need to take levodopa more frequently to maintain good symptom control.

What are motor fluctuations, “wearing off” and “on-off” times?

Motor fluctuations are changes in the ability to move. 

“On” time is when Parkinson’s medications (levodopa and dopamine agonists) take effect and you experience periods of good symptom control. 

“Wearing off” is when the drugs begin to lose effect and there are periods where symptoms worsen and movement becomes more difficult, known as “off” time.   

Other medications include:

  • Monoamine oxidase-B (MAO-B) inhibitors that make more dopamine available in the brain to improve movement symptoms. These include rasagiline, selegiline and safinamide.
  • Dopamine agonists to stimulate the parts of the brain influenced by dopamine — tricking the brain into thinking it is receiving the dopamine it needs. These include apomorphine, pramipexole, pramipexole ER, Ropinirole, Ropinirole XL and transdermal Rotigotine.
  • Catechol-O-methyl transferase (COMT) inhibitors entacapone, tolcapone and opicapone, which help with changes in the ability to move as levodopa wears off. Carbidopa-levodopa-entacapone improves motor fluctuations while lengthening the benefits of levodopa.
  • Antiglutamatergic medication amantadine. This can improve tremor and involuntary movements called dyskinesia that sometimes begin within a few years of taking levodopa. Its extended-release forms come in tablets and capsules.
  • Anticholinergics benztropine, biperiden and trihexyphenidyl. These are used for tremor and dystonia, painful cramping, in younger people. However, research shows cognitive slowing is a side effect of anticholinergics. These medications can also cause confusion and hallucinations in older adults and should not be used in people over 70.
  • Adenosine A2A antagonist istradefylline can reduce PD-related movement difficulties as levodopa wanes, known as “wearing off.”

People with PD can also experience a variety of non-movement symptoms, such as depression, anxiety, constipation, dizziness, hallucinations and more. The good news is that there are several prescription medications available for many of these symptoms.

Always talk to your Parkinson’s doctor about any medication concerns and side effects.

Room to Grow

There are several PD treatment options in the development pipeline. For some people with PD, current dopamine medicines fail to sufficiently address symptoms. Newer formulations that further improve and extend delivery are nearing approval. These drugs can minimize motor fluctuations and wearing off symptoms.

Two options for continuous levodopa infusion therapy are closer to getting the green light:

  • ABBV-951: AbbVie has completed trials and filed for U.S. Food and Drug Administration (FDA) approval of a carbidopa/levodopa formulation designed for continuous delivery under the skin, which aims to increase “on” time by reducing motor fluctuations.
  • ND0612: NeuroDerm recently completed clinical trials and is awaiting data on this new drug, which is a continuous subcutaneous carbidopa/levodopa infusion formula. The company expects to apply this year to U.S. and European regulatory industries for approval.

Studies have also been completed and published showing under-the-skin dopamine agonist apomorphine infusions can improve motor fluctuations in PD. Data has been submitted to the FDA for drug approval and is currently available in Europe.

For people newly diagnosed with Parkinson’s disease, P2B001 is a low-dose, extended-release formulation of pramipexole and rasagiline in development for the treatment of movement symptoms.

The FDA is reviewing Amneal’s IPX203, an extended-release carbidopa/levodopa tablet designed to extend PD symptom control while minimizing motor fluctuations.

In development, but further from the approval process, is Tavapadon, a once-daily tablet designed by Cerevel Therapeutics. It aims to target and activate certain dopamine receptors to improve PD motor symptoms while minimizing side effects sometimes related to other Parkinson’s therapies.

Among new therapies in development for cognitive symptoms is a formula from Anavex Life Sciences being evaluated for use in Parkinson’s disease dementia.

Putting the Brakes on PD

There is an active and ever-growing landscape of therapeutic trials aimed at slowing disease progression. In Parkinson’s, the protein alpha-synuclein misfolds and forms clumps in the brain called Lewy bodies. There are a number of experimental therapies in early development to either reduce alpha-synuclein production or minimize the forming of such clusters.

Though data from recent frontrunners targeting alpha-synuclein (prasinezumab and cinpanemab) failed to show slowing of PD progression, it can take decades to discover disease-modifying therapies.

A class of drugs approved to treat type 2 diabetes has also attracted a lot of attention for its potential to slow PD progression. Scientists across different studies in various stages of development are examining whether glucagon-like peptide-1 (GLP-1) receptor agonists can modify PD and improve symptoms.

Nilotinib, a drug approved for management of cancer, selectively inhibits tyrosine kinases, enzymes found in excess in some cancer cells. Tyrosine and other kinases have been linked to PD. Though studies of nilotinib did not improve PD biology, it was safe and tolerable in the small number of selected participants. Now, other novel cancer therapies are in the early stages of testing for potential effectiveness in PD.

There is also a lot of interest across neurodegenerative disease research in the gut-brain connection. This highlights the need for more studies that examine the role of inflammation in Parkinson's disease development.

PD and Personalized Medicine

Every person with Parkinson's experiences symptoms differently.  Developing therapies to target the biology of PD in a particular individual is known as personalized medicine. Genetic targeting is the most advanced way to subtype drug development for people with PD.

While those with Parkinson’s who carry a PD-related gene mutation currently constitute a minority of people with Parkinson's, the biology that drives their disease can be relevant even to people who do not carry the same mutation.

Researchers are investigating possible therapeutic interventions for two PD-related genes:

  • GBA, the most common Parkinson’s-related gene mutation, carried by up to 10% of people who live with the disease.
  • LRRK2, the gene variants involved in about 1% of all PD diagnoses and 5% of those for people with a family history. 

PD GENEration is a global initiative that offers comprehensive genetic testing and counseling for PD-related genes at no cost for people with Parkinson’s. It is critical to helping people determine whether they are candidates for gene-targeted medicine clinical trials. Knowledge of genetic status can also be important for therapeutic decision-making and for understanding individual disease progression, as well as potential implications for family.

Living Well Now

Taking control of the things you can early after diagnosis — creating healthy habits, embracing exercise and PD education and seeking out physical, occupational or speech therapy — can help address many aspects of Parkinson’s impacting your life right now.

Exercise, for example, is essential to managing many Parkinson’s symptoms and maintaining good function. Finding someone to talk to, such as a mental health therapist, can help you build coping skills and learn stress-easing strategies.

Helpful Resources

Explore more of our Parkinson’s management resources now:

Back to Top